Company Info

Strong Biotech Corporation is a market-oriented biotechnology company, which was established in June 2000. For the past 20 years, Strong has held fundamental immunology, microbiology, and proteomics technologies. Strong’s clinical gastroenterology professionals have specialized in Helicobacter pylori (H. pylori) in vitro diagnostic devices and related materials. Strong is the first company in the world specializing in producing both paper and gel type Helicobacter pylori in vitro diagnostic tests, providing rapid diagnosis of peptic ulcer caused by H. pylori as the basis of doctor’s prescription.

The R&D headquarters in Xizhi District, New Taipei City

We appreciate all shareholders and staff members, who have committed and devoted their efforts throughout the years. At SBC, fostering the corporate culture and raising corporate competency are the two most fundamental philosophies shared among every corporate member. On top of that, our core values are “”Superior,”” “”Beneficent,”” and “”Co-operative,”” which is also the acronym stands for Strong Biotech Corp., which lead us to have a prosperous future and become one of the pioneering corporates in the biotechnology industry.

The R&D headquarters in Xizhi District, New Taipei City

Now SBC proudly announces that we have successfully achieved our aims in Taiwan about developing the value chain. With efforts from different departments, such as R&D, manufacturing, and sales, we have expanded our global distribution networks and built our professional corporate branding to the world. Finally, I believe we can achieve our vision of continuously learning, innovating, and collaborating as a team to strive for the best performances.

公司介紹

GMP factory located in Tucheng District, New Taipei City

The R&D headquarters in Xizhi District, New Taipei City

The R&D headquarters in Xizhi District, New Taipei City

We appreciate all shareholders and staff members, who have committed and devoted their efforts throughout the years. At SBC, fostering the corporate culture and raising corporate competency are the two most fundamental philosophies shared among every corporate member. On top of that, our core values are “”Superior,”” “”Beneficent,”” and “”Co-operative,”” which is also the acronym stands for Strong Biotech Corp., which lead us to have a prosperous future and become one of the pioneering corporates in the biotechnology industry.

公司介紹

GMP factory located in Tucheng District, New Taipei City

Now SBC proudly announces that we have successfully achieved our aims in Taiwan about developing the value chain. With efforts from different departments, such as R&D, manufacturing, and sales, we have expanded our global distribution networks and built our professional corporate branding to the world. Finally, I believe we can achieve our vision of continuously learning, innovating, and collaborating as a team to strive for the best performances.

Goal Vision

As the world’s leading “Helicobacter pylori testing expert”, Strong Biotech Corp. is committed to providing excellent quality testing products and providing Helicobacter pylori infection prevention and gastric health care and repair solutions. At the same time, advanced biotechnology is used to develop the microbial application market and improve human quality of life. Currently, we are continuing to achieve the following future development goals:

Application of in vitro detection reagents


✽Human health
Early detection of diseases and infectious agents, providing accurate diagnosis and treatment guidance.

✽Animal health
Detect animal diseases, provide prevention and treatment, and increase economic value.

✽Environmental testing
It is used in environmental pollution to quickly detect water quality, air pollution, soil pollution and other issues, and provide scientific basis for corresponding prevention and treatment measures.

Green energy and environmental protection applications


✽Application of agricultural biotechnology
Combining green energy and sustainable agricultural technology to achieve environmental friendliness and resource conservation in the agricultural production process. Promote organic farming methods and reduce dependence on pesticides and chemical fertilizers.

✽Environmental and ecological improvement
Such as biodiversity conservation, water resources management and forest protection to improve the health of ecosystems. We are committed to ensuring the sustainable use of resources, reducing carbon emissions and mitigating climate change.

Marketing platform application


✽Integration with international marketing
By establishing a strong international marketing network, we strengthen cooperation with global partners, expand market scale, and use advanced data analysis and market trend research to accurately locate target customers.

✽Business-to-marketing integration
We provide customers with optimal solutions and transform scientific research results into commercial value, including new drug research and development, gene editing and biomanufacturing, and are committed to improving medical care and environmental protection.

Adhering to the business philosophy of “seeking truth from facts, innovative development” and the execution policy of “pragmatic innovation, stable operation”, Strong Biotech Corp., as an expert in microbial technology and application, we will continue to work hard to provide innovative development and high-quality products. , bringing continuous progress and value to social health, environmental protection and international markets.

Core Value

Gather the centripetal force of all members of Strong Biotech Corp., identify with the corporate culture, and form a conscientious cause of joint learning, innovation and progress, giving back to the society, and sustainable management.
The company’s abbreviated name SBC (Strong Biotech Corporation) establishes three core values :

Superior

Be proactive, pursue performance, and have the courage to change to demonstrate the ability to innovate and progress.

Beneficent

Fight diseases, prevent and treat medical treatments, and develop safe and effective products that patients demand.

Cooperative

Communicate well, build consensus, and achieve goals at each stage as scheduled.

Important Events

Chronicle Unite the collective focus and identify with the corporate culture, shaping into a conscientious enterprise that fosters communal learning, innovative progress, social contribution, and sustainable management.

2023

September- Business visit to Thailand for expansion.

July- Microfluidic rapid screening reagent project of National Defense Medical College.

May - Completed the industry-academia cooperation project with Southern Taiwan University of Science and Technology "Using the properties of polysaccharide prebiotics and active metabolites produced by the compound fermentation of parsley with lactic acid bacteria to develop new gastric health care materials that inhibit Helicobacter pylori".

March- National Central University lateral flow rapid screening technology development consulting and mentoring plan.

2022

December - Participate in the Taiwan Medical Technology Exhibition.

September - Participate in TDDW Taiwan Digestive Medicine Week.

September - Implementation of CE verification guidance for IVDR regulations.

August - HelicotecUT®Plus has modified configuration to improve performance.

March - Obtained Taiwan Medical Device Quality Management System Standards (QMS) certification.

January - Materials Application Research Project for Medical Rapid Screening at Central University.

2021

November - Chang Gung Memorial University's research project on optimization of apoptosis-targeting proteins.

August - Development of rapid screening reagent for Candida albicans.

July - CE certification renewal EU Authorized Representative.

April - Review and verification in response to the EU IVDR revision.

November - Cooperation project for the development of three-in-one rapid screening reagents.

November - Nucleic acid lateral flow immunoassay application environmental detection development cooperation case.

October - Participate in the Taiwan International Medical Exhibition.

January - HelicotecUT®Plus detection reagent performance upgrade.

2020

October - Participated in the Taiwan International Medical Exhibition.

July - Became a member of the "New Taipei City Biotechnology Industry Development Alliance".

January - Development of animal detection reagents.

2019

November - Participated in the Cross-Strait (Xiamen) Cultural Industry Expo and Trade Fair.

September - Participated in the theme meeting of Kaohsiung APTC Asia Pacific Society of Gastroenterology.

September - Participated in Xiamen CIFIT.

2018

November - Participated in the Cross-Strait (Xiamen) Cultural Industry Expo and Trade Fair.

May - H. pylori Antigen Rapid Test Kit gastric Helicobacter pylori antigen rapid test reagent obtained Taiwan's medical device license.

April - Obtained China's administrative license for importing special-purpose cosmetics.

January - Development of probiotics with efficacy against Helicobacter pylori.

2017

October - Participated in UEGW European Digestive Diseases Week in Spain.

September - Obtained the registration certificate for imported non-special purpose cosmetics from China.

September - Participated in the Guangdong International Beauty, Hairdressing and Cosmetics Import and Export Expo.

August - Obtained patent for Helicobacter pylori detection device.

June - Participated in Taipei International Beauty Care. Biotechnology and health care exhibition.

March - Business visit expansion in the UK and Türkiye.

2016

September - Participated in the Guangdong International Beauty, Hairdressing and Cosmetics Import and Export Expo.

May - Participated in the International Medical Exhibition in Sao Paulo, Brazil.

2015

December - Participated in APDW (Asia Pacific Digestive Week) Taipei Asia Pacific Digestive Medicine Week.

October - Female entrepreneurs from Yan'an came to visit.

September - Participated in the AGW & WGO exhibition in Brisbane, Australia.

September - Participated in Xiamen CIFIT.

July - Formulate annual audit plan and promote internal control system.

June - Factory visit and education training at INFAI Germany.

May - Participated in the IDDW Indonesia Digestive Disease Week exhibition in Indonesia.

May - Chongqing Chongqing Fair.

January - Imported ERP system.

2014

October - Participated in UEGW European Digestive Diseases Week in Vienna.

August - Developed microbial care products for medical beauty skin.

August - Business visit to Malaysia and Myanmar expanded.

March - The Helicobacter pylori detection device obtained German utility model registration.

2013

May - Participated in the DDW (Digestive Disease Week) Digestive Disease Week seminar in Orlando, USA.

July - Developed pepper lotion.

July - New formula optimization of HelicotecUT®Plus.

January - Established GMP licensed factory in “Yongning Science Park” Tucheng., New Taipei City fulfilling quality program and manufacturing process as required.

2012

July - “Innovation of novel Helicobacter pylori rapid urease test” project execution, funded by The Department of Economic Development, Taipei City Government.

May - “Innovation of immune-rapid test platform” SBIR project execution, funded by The Ministry of Economic Affairs, R.O.C.

March - the test stick was patented.

2011

January - The adoption of global integrated strategy to establish a MIT (Made In Taiwan) brand, specializing in developingIn Vitro Diagnostic (IVD) products” Project plan approval by The Ministry of Economic Affairs, R.O.C., Industrial Cooperation Program. Additional milestone include HelicotecUT® and HelicotecUT® Plusintroduced into Latin America.

2010

August - Recombinant expression of shrimp anti-lipoplysaccharide factor (SALF) in the involvement of anti-microbial activity research, Industry-University cooperative research project funded by the National Science Council, R.O.C. Additional milestone include HelicotecUT® and HelicotecUT® Plus launched in 36 countries worldwide.

2009

January - Successfully launched HelicotecUT® and HelicotecUT® Plus across 23 countries worldwide.

2008

October - Accredited CE marking for both HelicotecUT® and HelicotecUT®Plus, commenced global marketing & sales network.

August - Accredited ISO 13485:2003 and ISO 9001:2000 certification by word’s leading inspection, verification and testing company SGS-Taiwan.

July - SIIR (ASSTD) “The sandwich methodology for medical supply marketing” project execution, granted by The Ministry of Economic Affairs, R.O.C., Civil Service of Doc.

2007

July - Successfully developed apoptosis detection system of in vivo cell used for image diagnosis.

May - Developed a “New” in vitro diagnostic kit HelicotecUT®Plus in paper form for testing Helicobacter pylori and obtained the license from Department of Health, R.O.C. before sold to health system.

March - successfully established recombinant protein over expression and microbial fermentation technology which is applied in production of proteins and peptides in Medical Cosmetics. By the advanced technology in the field, we were invested in fermentative production of Medical Cosmetics new star, proteins and peptides in the family of Growth Factors.

2006

August - Executed “CITD” project on Annexin V derivative used in Image Diagnosis with Ministry of Economic Affairs, R.O.C. support.

anuary - Developed HelicotecUT® (An in vitro diagnostic kit in gel form for testing Helicobacter pylori) and obtained the IVD license from Department of Health, R.O.C.

2005

December - SBC Research products were divided into three major product lines: Apoptosis detection, Genomics and the Proteomics series. All of them have been highly recommended by the users of Research Labs and distributors in the field.

October – Participated in “SBIR” project on purification of xylitol from discarded wood flour together with major executive companies, San-Ying and Chung Hwa Pulp Corp. with grant support of Ministry of Economic Affairs, R.O.C. And developed several microbial strains producing enzymes for food industry.

2004

December - Completed “CITD” project and successfully developed apoptosis detection kit.

March - Executed “CITD” project on apoptosis detection kit with grant support of The Ministry of Economic Affairs, R.O.C.

January - Developed cloning vector for PCR system.

2003

November - Completed “SBIR” project and successfully developed stool diagnostic device.

2001

October - Executed “SBIR” project on stool diagnostic device for Helicobacter pylori with grant support of The Ministry of Economic Affairs, R.O.C.

2000

June - Strong Biotech Corporation was founded in Taiwan, R.O.C.